MENU
AKBA
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Akebia Therapeutics (AKBA) Ownership - Who owns Akebia Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
279.68M
P/E Ratio
N/A
Total Cash
39.5M
Projected Growth
N/A
Total Debt
49.51M
Revenue
174.5M
Risk (Beta)
0.27
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
0.88 USD as % of share price
Fundamentals
AKBA
Capitalization
280M
P/E Ratio
N/A
Risk (Beta)
0.27
Dividend Yield
N/A
Total Cash
39.5M
Total Cash/Share
0.19
Total Debt
49.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.88%
Revenue
174M
ROE
N/A
Book Value
-33.75M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
1.04
Current Revenue Per Employee
261365.27
Dividends Per Share - Security
N/A
EBITDA
4.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.94
Revenue To Assets
-17.07
Shares Held By Institutions
97.1M
Shares Outstanding - Current
210M
Total Liabilities
254M
Total Volume MTD
N/A
Value
-1
Gain YTD
7.258
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts